If you are:
FDB Only When Necessary: AVAILABLE DATA SUGGEST NO KNOWN RISK; OTC PRODUCT, NO FDA PREGNANCY WARNINGS
FDB Only When Necessary: NEONATE SEIZURE/WITHDRAWAL SYN/FETAL DEATH REPORTED;SMALL TERATOGENIC RISK
No Known Risk: LOW LEVELS EXCRETED WITH LOW RISK FOR ADVERSE EFFECTS IN INFANT
Absolute Contraindication: LOW AMOUNTS EXCRETED; MONITOR FOR RESPIRATORY DEPRESSION
An adult over 60:
management or monitoring precaution: General-Dosage reduction may be needed, depending on renal and hepatic status. Start at low initial doses and titrate slowly. Pulmonary-Respiratory depression is the chief risk for elderly. Neuro/Psych-Lowers seizure threshold; may be acceptable in patients with well-controlled seizures in whom alternative agents have not been effective. Risk for increased confusion and delirium. May increase fall risk. Avoid treatment with 3 or more CNS active drugs
management or monitoring precaution: Hepatic-Elderly are more susceptible to hepatotoxicity. Strict adherence to a maximum daily dose of 3000mg is advised.
Giving TRAMADOL HCL-ACETAMINOPHEN to a child under 12:
management or monitoring precaution: Use weight based dosing in children less than 12 years.
Severe Precaution: Contraindicated post adenoidectomy and/or tonsillectomy, Risk of slowed or difficult breathing and respiratory depression. Avoid in patient with obstructive sleep apnea, lung disease.
Contraindication: Risk of slowed or difficult breathing and respiratory depression. Contraindicated age< 12 years,